Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide - CNBC

[News]

1. Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide CNBC
2. Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market Yahoo Finance
3. Amgen obesity drug MariTide: four key questions going forward - STAT STAT
4. Novo Nordisk's Ozempic Stock Rally Is Hitting a Wall The Wall Street Journal
5. Novo Slides as Amgen Fuels Obesity Drug Competition Fears Bloomberg

Okumaya devam et...